ATXI: avenuetx.com Market Valuation

Public company logo of Avenue Therapeutics, Inc. (ATXI)

Avenue Therapeutics develops therapies for CNS pathologies, focusing on the hospital segment and the fight against opioid addiction. The team brings together leading neurologists to whom the firm provides resources and scientific autonomy. The asset's market capitalization stands at 0.00, while the business operates in an autonomous cycle independent of macroeconomics. This daily price chart for (ATXI) is presented below.

Avenue Therapeutics, Inc. - ATXI Market Capitalization (period 07/04/2022 - 03/29/2025)

ATXI (Avenue Therapeutics, Inc.): analytical breakdowns and indicator data

Fundamental company analysis:ATXI (Avenue Therapeutics, Inc)
Product sample of avenuetx.com

Avenue Therapeutics (ATXI) neurological drug development is sensitive to the stability of global chemical component supply chains. Analyzing the company's market capitalization chart allows for tracking the market reaction to geopolitical risks. This indicator is calculated as the product of the current share price and the total number of outstanding securities. This metric reflects aggregate investor expectations rather than the intrinsic value of the assets. A sharp increase in valuation may signal that the asset is overbought amid inflated forecasts.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Inhibikase Therapeutics Inc (IKT)|Cassava - Market Valuation|assertiotx.com (ASRT) - Market Value|COYA - Market Value|Market Value VTGN (VistaGen Therapeutics, Inc.)|OVID: Market Capitalization|Acumen Pharmaceuticals Inc. (ABOS) - Market Capitalization|Market Value CervoMed Inc.|ATHE: Market Value|Market Value Clene (CLNN)|PEPG: Market Valuation|Market Value Jupiter Neurosciences, Inc. JUNS|Market Capitalization Relmada Therapeutics Inc RLMD|ANVS - Market Value|GRCE - Market Capitalization|AIFF: Market Capitalization|KLTO - Market Capitalization|NRSN (NeuroSense Therapeutics, Ltd.) - Market Capitalization|Market Capitalization Reviva Pharmaceuticals Holdings|Market Capitalization MTVA|Market Capitalization NeurAxis Inc|Helius Medical Technologies - Market Valuation|Market Capitalization Passage Bio, Inc. PASG|NEUP: Market Valuation|Minerva Neurosciences, Inc. (NERV) - Market Valuation|ATHA (Athira Pharma) - Market Valuation|Market Capitalization ADXN|Market Value Alzamend Neuro, Inc.|Market Valuation cyclerion.com (CYCN)|Market Capitalization PTIX|Market Capitalization Pasithea (KTTA)|Market Value Cortigent CRGT|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics